Validity and prognostic predictive ability of Strength,Assistance with walking,Rise from a chair, Climb stairs and Falls sarcopenia score in the hospitalized elderly
10.3760/cma.j.issn.1672-7088.2018.11.007
- VernacularTitle:SARC-F评分对住院老年人肌少症筛查的准确性及预后预测能力评价
- Author:
Min LI
1
;
Guiqi SONG
;
Xiaoling WANG
;
Xin SUN
;
Ying ZHANG
;
Yan CUI
Author Information
1. 中国科学技术大学附属第一医院 安徽省立医院老年科
- Keywords:
Aged;
Sarcopenia;
Score;
Screening
- From:
Chinese Journal of Practical Nursing
2018;34(11):832-836
- CountryChina
- Language:Chinese
-
Abstract:
Objective To assess the validity of Strength, Assistance with walking, Rise from a chair, Climb stairs and Falls (SARC-F) sarcopenia score in the hospitalized elderly and its prognostic predictive ability in predicting the adverse outcomes of sarcopenia. Methods Totally 113 hospitalized elderly who met the inclusion and exclusion criteria were included.Took diagnostic criteria recommended by Asian Sarcopenia Working Group as the reference,the validity of SARC-F score were evaluated using the sensitivity, specificity, ROC curve and other indexes. According to the score, the patients were dichotomously classified into sarcopniac and normal groups.The adverse consequences of two groups were followed up.The incidence of falls,fractures,re-hospitalization and death were compared between the two groups. Survival curves were used to analyze whether there was any difference in re-hospitalization time between the two groups.The Cox proportional hazards model was used to determine the factors influencing the prognosis (re-hospitalization time). Results The accuracy evaluation of SARC-F score: the area under the curve of ROC(AUC)was 0.73,95% confidence interval(95% CI):0.62-0.84,P<0.01;the cutoff of 3 reached the highest Youden′s index.The results of the follow-up of SARC-F:103 patients completed the follow-up,in the normal group divided by SARC-F,the incidence rate of re-hospitalization,fall,and fracture within one year were 20.00%(17/85),3.53%(3/85),0,which were significantly lower than 44.44% (8/18),27.78%(5/18),16.67 %(3/18)of the sarcopeniac group(Χ2=4.829,5.509,all P<0.05).The Kaplan-Meier survival curve showed a statistically significant difference in the interval time of re-hospitalization between the two groups divided by SARC-F(218.53 days vs.389.41 days,log-rank Χ2=17.584,P<0.01). Cox analysis displayed usual gait speed was the protective factors for readmission, SARC-F, Charlson comorbidity index were independent risk factors for readmission. Conclusions SARC-F score is valuable for screening for sarcopenia in elderly inpatients. SARC-F score is a predictor of adverse outcomes in elderly inpatients including re-hospitalization, falls and fractures. SARC-F score is an independent risk factor for re-hospitalization,but the prognosis is influenced by a variety of factors.The evaluation of SARC-F prognostic value requires the consideration of the basic disease.
